Bio-One acquisition
This article was originally published in The Tan Sheet
Executive Summary
Orlando, Fla.-based supplement firm purchases fifth majority stake in a Chinese herbal company in recent months with acquisition of 51% share of a firm in the Henan Province; the acquisition is expected to close in 90 days. The Chinese firm, which reported $17 mil. in 2003 revenues, will retain its present management team. The deal continues Bio-One's vertical integration and international expansion strategy following the April purchase of Canadian distributor and manufacturer INI (1"The Tan Sheet" April 12, 2004, p. 12)...
You may also be interested in...
Bio-One Supplement Firm Buys Interactive Nutrition International
Bio-One continues its aggressive acquisition strategy with its purchase of Canadian manufacturer and distributor Interactive Nutrition International, the firm announced April 1
Despite 'Remarkable' ROI On Women’s Health Investments, Money Still Lacking
Recent US government initiatives and growing investor interest are important for developing female-specific therapeutics, but funding is not yet where it should be.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues in an interview with Scrip.